BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24995870)

  • 1. Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life.
    Thevenon J; Milh M; Feillet F; St-Onge J; Duffourd Y; Jugé C; Roubertie A; Héron D; Mignot C; Raffo E; Isidor B; Wahlen S; Sanlaville D; Villeneuve N; Darmency-Stamboul V; Toutain A; Lefebvre M; Chouchane M; Huet F; Lafon A; de Saint Martin A; Lesca G; El Chehadeh S; Thauvin-Robinet C; Masurel-Paulet A; Odent S; Villard L; Philippe C; Faivre L; Rivière JB
    Am J Hum Genet; 2014 Jul; 95(1):113-20. PubMed ID: 24995870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia.
    Hardies K; de Kovel CG; Weckhuysen S; Asselbergh B; Geuens T; Deconinck T; Azmi A; May P; Brilstra E; Becker F; Barisic N; Craiu D; Braun KP; Lal D; Thiele H; Schubert J; Weber Y; van 't Slot R; Nürnberg P; Balling R; Timmerman V; Lerche H; Maudsley S; Helbig I; Suls A; Koeleman BP; De Jonghe P;
    Brain; 2015 Nov; 138(Pt 11):3238-50. PubMed ID: 26384929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal developmental and epileptic encephalopathy due to autosomal recessive variants in SLC13A5 gene.
    Matricardi S; De Liso P; Freri E; Costa P; Castellotti B; Magri S; Gellera C; Granata T; Musante L; Lesca G; Oertel J; Craiu D; Hammer TB; Møller RS; Barisic N; Abou Jamra R; Polster T; Vigevano F; Marini C
    Epilepsia; 2020 Nov; 61(11):2474-2485. PubMed ID: 33063863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC13A5 is the second gene associated with Kohlschütter-Tönz syndrome.
    Schossig A; Bloch-Zupan A; Lussi A; Wolf NI; Raskin S; Cohen M; Giuliano F; Jurgens J; Krabichler B; Koolen DA; de Macena Sobreira NL; Maurer E; Muller-Bolla M; Penzien J; Zschocke J; Kapferer-Seebacher I
    J Med Genet; 2017 Jan; 54(1):54-62. PubMed ID: 27600704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Homozygous Variants of SLC13A5 Expand the Functional Heterogeneity of a Homogeneous Syndrome of Early Infantile Epileptic Encephalopathy.
    Alsemari A; Guzmán-Vega FJ; Meyer BF; Arold ST
    Pediatr Neurol; 2024 Feb; 151():68-72. PubMed ID: 38113697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal-Recessive Mutations in AP3B2, Adaptor-Related Protein Complex 3 Beta 2 Subunit, Cause an Early-Onset Epileptic Encephalopathy with Optic Atrophy.
    Assoum M; Philippe C; Isidor B; Perrin L; Makrythanasis P; Sondheimer N; Paris C; Douglas J; Lesca G; Antonarakis S; Hamamy H; Jouan T; Duffourd Y; Auvin S; Saunier A; Begtrup A; Nowak C; Chatron N; Ville D; Mireskandari K; Milani P; Jonveaux P; Lemeur G; Milh M; Amamoto M; Kato M; Nakashima M; Miyake N; Matsumoto N; Masri A; Thauvin-Robinet C; Rivière JB; Faivre L; Thevenon J
    Am J Hum Genet; 2016 Dec; 99(6):1368-1376. PubMed ID: 27889060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel homozygous SLC13A5 whole-gene deletion generated by Alu/Alu-mediated rearrangement in an Iraqi family with epileptic encephalopathy.
    Duan R; Saadi NW; Grochowski CM; Bhadila G; Faridoun A; Mitani T; Du H; Fatih JM; Jhangiani SN; Akdemir ZC; Gibbs RA; Pehlivan D; Posey JE; Marafi D; Lupski JR
    Am J Med Genet A; 2021 Jul; 185(7):1972-1980. PubMed ID: 33797191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC13A5 Deficiency Disorder: From Genetics to Gene Therapy.
    Goodspeed K; Liu JS; Nye KL; Prasad S; Sadhu C; Tavakkoli F; Bilder DA; Minassian BA; Bailey RM
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A de novo missense mutation in SLC12A5 found in a compound heterozygote patient with epilepsy of infancy with migrating focal seizures.
    Saito T; Ishii A; Sugai K; Sasaki M; Hirose S
    Clin Genet; 2017 Dec; 92(6):654-658. PubMed ID: 28477354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamazepine efficacy in a severe electro-clinical presentation of SLC13A5-epilepsy.
    Santalucia R; Vilain C; Soblet J; De Laet C; Vuckovic A; König J; Aeby A
    Ann Clin Transl Neurol; 2022 Jul; 9(7):1095-1099. PubMed ID: 35633140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the sodium-dependent citrate transporter SLC13A5 in mice causes alterations in brain citrate levels and neuronal network excitability in the hippocampus.
    Henke C; Töllner K; van Dijk RM; Miljanovic N; Cordes T; Twele F; Bröer S; Ziesak V; Rohde M; Hauck SM; Vogel C; Welzel L; Schumann T; Willmes DM; Kurzbach A; El-Agroudy NN; Bornstein SR; Schneider SA; Jordan J; Potschka H; Metallo CM; Köhling R; Birkenfeld AL; Löscher W
    Neurobiol Dis; 2020 Sep; 143():105018. PubMed ID: 32682952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: a case of pharmaco-synergistic heterozygosity.
    Kopel J; Grooms A; Ganapathy V; Clothier J
    Psychiatr Genet; 2021 Feb; 31(1):32-35. PubMed ID: 33290383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the Na(+)/citrate cotransporter NaCT (SLC13A5) in pediatric patients with epilepsy and developmental delay.
    Klotz J; Porter BE; Colas C; Schlessinger A; Pajor AM
    Mol Med; 2016 May; 22():310-21. PubMed ID: 27261973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Membrane Na⁺-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy.
    Bhutia YD; Kopel JJ; Lawrence JJ; Neugebauer V; Ganapathy V
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, radiological, and genetic characterization of
    AlQudairy H; AlDhalaan H; AlRuways S; AlMutairi N; AlNakiyah M; AlGhofaili R; AlBakheet A; Alomrani A; Alharbi OA; Tous E; AlSayed M; AlZaidan H; AlRasheed MM; AlOdaib A; Kaya N
    Front Pediatr; 2022; 10():1051534. PubMed ID: 36923948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental and epileptic encephalopathy 82 (DEE82) with novel compound heterozygous mutations of GOT2 gene.
    Çapan ÖY; Türkdoğan D; Atalay S; Çağlayan HS
    Seizure; 2024 Mar; 116():126-132. PubMed ID: 37977948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Punctate white matter lesions in full-term infants with neonatal seizures associated with SLC13A5 mutations.
    Weeke LC; Brilstra E; Braun KP; Zonneveld-Huijssoon E; Salomons GS; Koeleman BP; van Gassen KL; van Straaten HL; Craiu D; de Vries LS
    Eur J Paediatr Neurol; 2017 Mar; 21(2):396-403. PubMed ID: 27913086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle.
    Bainbridge MN; Cooney E; Miller M; Kennedy AD; Wulff JE; Donti T; Jhangiani SN; Gibbs RA; Elsea SH; Porter BE; Graham BH
    Mol Genet Metab; 2017 Aug; 121(4):314-319. PubMed ID: 28673551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAT1 encephalopathy: a recessive cause of epilepsy of infancy with migrating focal seizures.
    Scheffer IE; Boysen KE; Schneider AL; Myers CT; Mehaffey MG; Rochtus AM; Yuen YP; Ronen GM; Chak WK; Gill D; Poduri A; Mefford HC
    Dev Med Child Neurol; 2020 Sep; 62(9):1096-1099. PubMed ID: 31868227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asparagine synthetase deficiency detected by whole exome sequencing causes congenital microcephaly, epileptic encephalopathy and psychomotor delay.
    Ben-Salem S; Gleeson JG; Al-Shamsi AM; Islam B; Hertecant J; Ali BR; Al-Gazali L
    Metab Brain Dis; 2015 Jun; 30(3):687-94. PubMed ID: 25227173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.